NPIPB13
gene geneOn this page
Summary
NPIPB13 (nuclear pore complex interacting protein family, member B13, HGNC:41989) is a protein-coding gene on chromosome 16p11.2, encoding Nuclear pore complex-interacting protein family member B13 (A6NJU9).
Predicted to be located in membrane.
Source: NCBI Gene 613037 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_001395859
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:41989 |
| Approved symbol | NPIPB13 |
| Name | nuclear pore complex interacting protein family, member B13 |
| Location | 16p11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000198064 |
| Ensembl biotype | protein_coding |
| Entrez | 613037 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 10 protein_coding, 3 nonsense_mediated_decay
ENST00000520915, ENST00000562937, ENST00000564219, ENST00000564502, ENST00000568053, ENST00000697092, ENST00000697187, ENST00000697188, ENST00000697189, ENST00000697190, ENST00000697191, ENST00000908420, ENST00000928769
RefSeq mRNA: 4 — MANE Select: NM_001395859
NM_001321892, NM_001395859, NM_001395860, NM_001395861
CCDS: CCDS81968
Canonical transcript exons
ENST00000697092 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003458505 | 30231440 | 30231635 |
| ENSE00003459637 | 30245454 | 30245611 |
| ENSE00003576281 | 30231748 | 30231847 |
| ENSE00003588040 | 30227309 | 30227369 |
| ENSE00003645530 | 30245775 | 30248479 |
| ENSE00003654619 | 30235451 | 30235579 |
| ENSE00003685704 | 30227164 | 30227199 |
| ENSE00003969482 | 30222897 | 30225803 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 96.40.
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 96.40 | gold quality |
| colonic epithelium | UBERON:0000397 | 95.45 | gold quality |
| bone marrow cell | CL:0002092 | 91.12 | gold quality |
| bone marrow | UBERON:0002371 | 86.46 | gold quality |
| corpus callosum | UBERON:0002336 | 85.96 | gold quality |
| tonsil | UBERON:0002372 | 85.76 | gold quality |
| calcaneal tendon | UBERON:0003701 | 84.54 | gold quality |
| primary visual cortex | UBERON:0002436 | 84.12 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 83.96 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 83.64 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 83.44 | gold quality |
| stromal cell of endometrium | CL:0002255 | 82.53 | gold quality |
| uterine cervix | UBERON:0000002 | 82.05 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.82 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 81.47 | gold quality |
| cerebellum | UBERON:0002037 | 81.06 | gold quality |
| cerebellar cortex | UBERON:0002129 | 80.88 | gold quality |
| zone of skin | UBERON:0000014 | 80.83 | gold quality |
| skin of abdomen | UBERON:0001416 | 80.82 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 80.69 | gold quality |
| blood | UBERON:0000178 | 80.66 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 80.63 | gold quality |
| skin of leg | UBERON:0001511 | 80.56 | gold quality |
| liver | UBERON:0002107 | 80.41 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 79.98 | gold quality |
| granulocyte | CL:0000094 | 79.94 | gold quality |
| cortex of kidney | UBERON:0001225 | 79.93 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 79.89 | gold quality |
| left ovary | UBERON:0002119 | 79.47 | gold quality |
| ectocervix | UBERON:0012249 | 79.40 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 6.47 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
29 targeting NPIPB13, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-6759-5P | 99.99 | 66.54 | 785 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-6793-5P | 99.97 | 65.95 | 758 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-MIR-137-3P | 99.87 | 74.74 | 2401 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
| HSA-MIR-548AC | 99.84 | 70.77 | 4351 |
| HSA-MIR-548H-3P | 99.84 | 70.80 | 4349 |
| HSA-MIR-548Z | 99.84 | 70.80 | 4349 |
| HSA-MIR-6844 | 99.82 | 70.69 | 2423 |
| HSA-MIR-3934-3P | 99.76 | 65.51 | 1351 |
| HSA-MIR-17-3P | 99.55 | 66.77 | 1311 |
| HSA-MIR-330-3P | 99.41 | 69.95 | 2521 |
| HSA-MIR-6739-3P | 99.22 | 68.84 | 1843 |
| HSA-MIR-4744 | 99.01 | 69.91 | 1581 |
| HSA-MIR-4742-5P | 98.89 | 68.41 | 1542 |
| HSA-MIR-4703-5P | 98.53 | 70.13 | 1645 |
| HSA-MIR-3942-5P | 98.52 | 69.51 | 1517 |
| HSA-MIR-6771-3P | 98.20 | 66.53 | 971 |
| HSA-MIR-122-5P | 97.23 | 64.92 | 1024 |
| HSA-MIR-1288-3P | 96.86 | 66.95 | 536 |
| HSA-MIR-3169 | 96.40 | 67.58 | 698 |
| HSA-MIR-5195-5P | 90.84 | 65.09 | 287 |
Cross-species orthologs
0 orthologs
Paralogs (19): NPIPB12 (ENSG00000169203), NPIPB3 (ENSG00000169246), NPIPA1 (ENSG00000183426), NPIPA5 (ENSG00000183793), NPIPA6 (ENSG00000183889), NPIPB4 (ENSG00000185864), NPIPB15 (ENSG00000196436), NPIPB9 (ENSG00000196993), NPIPB6 (ENSG00000198156), NPIPA8 (ENSG00000214940), NPIPA7 (ENSG00000214967), NPIPA3 (ENSG00000224712), NPIPA9 (ENSG00000233024), NPIPB7 (ENSG00000233232), NPIPB2 (ENSG00000234719), NPIPB5 (ENSG00000243716), NPIPB11 (ENSG00000254206), NPIPA2 (ENSG00000254852), NPIPB8 (ENSG00000255524)
Protein
Protein identifiers
Nuclear pore complex-interacting protein family member B13 — A6NJU9 (reviewed: A6NJU9)
All UniProt accessions (10): A6NJU9, A0A1P7U241, A0A8V8TKT1, A0A8V8TKU4, A0A8V8TL61, A0A8V8TM43, A0A8V8TMC5, E5RHP9, F5GWQ4, H3BQU5
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Similarity. Belongs to the NPIP family.
RefSeq proteins (4): NP_001308821, NP_001382788, NP_001382789, NP_001382790 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR009443 | NPIP | Family |
| IPR048893 | NPB13-like_MII_rpt | Repeat |
| IPR054697 | NPIP_N | Domain |
Pfam: PF06409, PF20885
UniProt features (16 total): compositionally biased region 12, region of interest 2, chain 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NJU9-F1 | 43.87 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 12 (showing top):
chr16p11, LU_EZH2_TARGETS_DN, JOHNSTONE_PARVB_TARGETS_3_DN, MIR616_5P, MIR371B_5P, MIR373_5P, MIR6844, MIR4744, MIR3934_3P, JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP, JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN, TRAVAGLINI_LUNG_NEUTROPHIL_CELL
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
699 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NPIPB13 | KRTAP5-7 | Q6L8G8 | 574 |
| NPIPB13 | DEPDC4 | Q8N2C3 | 447 |
| NPIPB13 | KRTAP4-8 | Q9BYQ9 | 444 |
| NPIPB13 | MTRNR2L3 | P0CJ70 | 433 |
| NPIPB13 | OR1F1 | O43749 | 431 |
| NPIPB13 | CSTL1 | Q9H114 | 359 |
| NPIPB13 | CCSER2 | Q9H7U1 | 350 |
| NPIPB13 | SLC25A47 | Q6Q0C1 | 325 |
| NPIPB13 | NWD2 | Q9ULI1 | 321 |
| NPIPB13 | CLEC17A | Q6ZS10 | 316 |
| NPIPB13 | PHYHD1 | Q5SRE7 | 307 |
| NPIPB13 | OSGEPL1 | Q9H4B0 | 305 |
| NPIPB13 | GFOD1 | Q9NXC2 | 305 |
| NPIPB13 | ZBTB8OS | Q8IWT0 | 305 |
| NPIPB13 | MIR9-1HG | Q13536 | 294 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A023PXQ4, A0A0U1RQI7, A6NJU9, A6NNC1, A8MRT5, A8MUU9, C9JG80, E2RYF6, E5RHQ5, F8W0I5, O13534, O59779, P08399, P0C732, P0C785, P0DTH6, P0DW28, P13208, P15941, P21787, P24856, P39564, P51861, P87269, Q00130, Q01456, Q12444, Q13117, Q1HVI8, Q27905, Q2EEQ3, Q4ZJY7, Q4ZJZ0, Q5SDL7, Q63661, Q69577, Q6B0Y1, Q6RY98, Q6ZQT0, Q6ZRX8
Diamond homologs: A0A0B4J1W7, A6NHN6, A6NJ64, A6NJU9, A8MRT5, C9JG80, E5RHQ5, E9PIF3, E9PJ23, E9PJI5, E9PKD4, E9PQR5, F8W0I5, F8W1W9, F8WFD2, O75200, P0DM63, P0DXC3, Q92617, Q9UND3, O70490, Q08AH1, Q08AH3, Q3UNX5, Q53FZ2, Q5REV5, Q68CK6, Q6AYT9, Q6NUN0, Q6SKG1, Q8BGA8, Q8K0L3, Q91VA0, Q9BEA2, A0A179HJB8, A4YDT1, C0SPB0, P0C7M7, P39062, Q6P461
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
861 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:30231438:A:AC | donor_gain | 1.0000 |
| 16:30231439:C:CC | donor_gain | 1.0000 |
| 16:30231746:ACCTT:A | donor_gain | 1.0000 |
| 16:30231747:CCTTC:C | donor_gain | 1.0000 |
| 16:30231750:T:A | donor_gain | 1.0000 |
| 16:30231845:CAC:C | acceptor_gain | 1.0000 |
| 16:30235443:ATACT:A | donor_loss | 1.0000 |
| 16:30235445:ACT:A | donor_loss | 1.0000 |
| 16:30235446:CTC:C | donor_loss | 1.0000 |
| 16:30235448:CA:C | donor_loss | 1.0000 |
| 16:30235449:A:AC | donor_gain | 1.0000 |
| 16:30235449:AC:A | donor_gain | 1.0000 |
| 16:30235449:ACC:A | donor_gain | 1.0000 |
| 16:30235450:C:CT | donor_gain | 1.0000 |
| 16:30235450:CC:C | donor_gain | 1.0000 |
| 16:30235450:CCC:C | donor_gain | 1.0000 |
| 16:30235450:CCCA:C | donor_gain | 1.0000 |
| 16:30235450:CCCAA:C | donor_gain | 1.0000 |
| 16:30235529:TCC:T | donor_gain | 1.0000 |
| 16:30227307:A:AC | donor_gain | 0.9900 |
| 16:30227308:C:CC | donor_gain | 0.9900 |
| 16:30228487:T:TC | acceptor_gain | 0.9900 |
| 16:30231635:CCT:C | acceptor_gain | 0.9900 |
| 16:30231637:T:C | acceptor_gain | 0.9900 |
| 16:30231742:CCATA:C | donor_loss | 0.9900 |
| 16:30231743:CATAC:C | donor_loss | 0.9900 |
| 16:30231744:ATAC:A | donor_loss | 0.9900 |
| 16:30231745:TA:T | donor_loss | 0.9900 |
| 16:30231746:ACC:A | donor_loss | 0.9900 |
| 16:30231747:C:G | donor_loss | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1005884264 (16:30231803 A>G), RS1006328338 (16:30225448 G>C,T), RS1006560765 (16:30244851 T>A), RS1007722746 (16:30246474 T>C), RS1013897487 (16:30230752 G>A), RS1015941302 (16:30232006 T>G), RS1016007980 (16:30225477 A>G,T), RS1018191438 (16:30246667 C>T), RS1030070923 (16:30245398 C>T), RS1031177352 (16:30232419 G>T), RS1031609589 (16:30246778 G>A), RS1037343252 (16:30244860 T>C,G), RS1037606735 (16:30247276 A>T), RS1043483120 (16:30230479 C>G,T), RS1044975783 (16:30230799 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| triphenyl phosphate | affects expression | 1 |
| Gallic Acid | increases expression | 1 |
| Gasoline | affects cotreatment, increases abundance, increases expression | 1 |
| Polycyclic Aromatic Hydrocarbons | increases expression, affects cotreatment, increases abundance | 1 |
| Asbestos, Crocidolite | decreases expression | 1 |
| Particulate Matter | affects cotreatment, increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.